Zobrazeno 1 - 10 of 37 pro vyhledávání: '"Moes RGJ"'
1
Akademický článek
Evaluating the Clinical and Economic Outcomes Associated with Poor Glycemic Control in People with Type 1 Diabetes in the Netherlands
Autor: Moes RGJ, Huisman EL, Malkin SJP, Hunt B
Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 87-96 (2023)
Robert Gerald Jan Moes,1 Eline L Huisman,1 Samuel JP Malkin,2 Barnaby Hunt2 1Novo Nordisk BV, Alphen aan den Rijn, Netherlands; 2Ossian Health Economics and Communications, Basel, SwitzerlandCorrespondence: Barnaby Hunt, Ossian Health Economics and C
Externí odkaz: https://doaj.org/article/7d81cffd3f774331aa0f08a6dc07845b
Zobrazit plný text záznamu
2
Akademický článek
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial.
Autor: Evans M; University Hospital Llandough, Penarth, UK. marclyndon1@hotmail.com., Moes RGJ; Novo Nordisk B.V., Alphen aan den Rijn, Netherlands., Pedersen KS; Novo Nordisk Region Europe, Copenhagen, Denmark., Gundgaard J; Novo Nordisk A/S, Søborg, Denmark., Pieber TR; Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Publikováno v: Advances in therapy [Adv Ther] 2020 May; Vol. 37 (5), pp. 2413-2426. Date of Electronic Publication: 2020 Apr 18.
Zobrazit plný text záznamu
3
Akademický článek
Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands.
Autor: Hunt B; Ossian Health Economics and Communications, Basel, Switzerland., Malkin SJP; Ossian Health Economics and Communications, Basel, Switzerland., Moes RGJ; Novo Nordisk Farma, Alphen aan den Rijn, The Netherlands., Huisman EL; Novo Nordisk Farma, Alphen aan den Rijn, The Netherlands., Vandebrouck T; SA Novo Nordisk Pharma, Brussels, Belgium., Wolffenbuttel BHR; University Medical Center Groningen, Groningen, The Netherlands.
Publikováno v: BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2019 Oct 01; Vol. 7 (1), pp. e000705. Date of Electronic Publication: 2019 Oct 01 (Print Publication: 2019).
Zobrazit plný text záznamu
4
Akademický článek
Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study.
Autor: Gourdy, Pierre1,2 (AUTHOR), Darmon, Patrice3,4 (AUTHOR), Borget, Isabelle5 (AUTHOR), Emery, Corinne6 (AUTHOR), Bureau, Isabelle6 (AUTHOR), Detournay, Bruno6 (AUTHOR) Bruno.detournay@cemka.fr, Bahloul, Amar7 (AUTHOR), Allali, Noemie7 (AUTHOR), Mahieu, Aymeric7 (AUTHOR), Penfornis, Alfred8 (AUTHOR)
Publikováno v: Diabetes Therapy. Jun2024, Vol. 15 Issue 6, p1349-1360. 12p.
Zobrazit plný text záznamu
5
Akademický článek
Evaluating the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Liraglutide 1.8 mg: A Health Economic Analysis in the UK.
Autor: Evans, Marc1 (AUTHOR) marclyndon1@hotmail.com, Berry, Sasha2 (AUTHOR), Malkin, Samuel J. P.3 (AUTHOR), Hunt, Barnaby3 (AUTHOR), Sharma, Abheet4 (AUTHOR)
Publikováno v: Diabetes Therapy. Jun2023, Vol. 14 Issue 6, p1005-1021. 17p.
Zobrazit plný text záznamu
6
Akademický článek
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China.
Autor: Liu, Lei1 (AUTHOR), Ruan, Zhen2 (AUTHOR), Ung, Carolina Oi Lam2,3 (AUTHOR), Zhang, Yawen4 (AUTHOR), Shen, Yang5 (AUTHOR), Han, Sheng6 (AUTHOR), Jia, Ruxu7 (AUTHOR), Qiao, Jingtao8 (AUTHOR), Hu, Hao2,3 (AUTHOR) haohu@um.edu.mo, Guo, Lixin8 (AUTHOR) glx1218@163.com
Publikováno v: Diabetes Therapy. Jan2023, Vol. 14 Issue 1, p93-107. 15p.
Zobrazit plný text záznamu
7
Akademický článek
Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China.
Autor: Ruan, Zhen1 (AUTHOR), Ung, Carolina Oi Lam1,2 (AUTHOR), Shen, Yang3 (AUTHOR), Zhang, Yawen3 (AUTHOR), Wang, Weihao4 (AUTHOR), Luo, Jingyi4 (AUTHOR), Zou, Huimin1 (AUTHOR), Xue, Yan1 (AUTHOR), Wang, Yao1 (AUTHOR), Hu, Hao1,2 (AUTHOR) haohu@um.edu.mo, Guo, Lixin4 (AUTHOR) glx1218@163.com
Publikováno v: Diabetes Therapy. Oct2022, Vol. 13 Issue 10, p1737-1753. 17p.
Zobrazit plný text záznamu
9
Akademický článek
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications.
Autor: Alharbi, Saleh Hadi
Publikováno v: Therapeutic Advances in Endocrinology & Metabolism; 1/27/2024, p1-18, 18p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje